This inventor holds 3 USPTO granted patents. Top assignee: Infigen, Inc.. Active years: 2000-2003.
Company Filing History:
Years Active: 2000-2003
Title: Marvin M. Pace: Innovator in Cloning Technologies
Introduction
Marvin M. Pace is a notable inventor based in DeForest, Wisconsin, who has made significant contributions to the field of cloning technologies. With a total of three patents to his name, he has focused on advancing methods that enhance the understanding and application of cloning in animals.
Latest Patents
Among his latest patents, Marvin has developed a "Method of Cloning Animals," which relates to cloning technologies. This invention involves immortalized and totipotent cells that are useful for cloning animals, as well as the embryos produced from these cells using nuclear transfer techniques. Additionally, he has patented a "Method of Producing a Polypeptide in an Ungulate," which also pertains to cloning technologies and shares similar foundational concepts regarding the use of cells and embryos.
Career Highlights
Marvin M. Pace is currently associated with Infigen, Inc., where he continues to work on innovative solutions in the field of biotechnology. His expertise in cloning technologies has positioned him as a key figure in advancing scientific research and applications.
Collaborations
Throughout his career, Marvin has collaborated with notable colleagues, including Nikolai S. Strelchenko and Jeffrey M. Betthauser. These collaborations have further enriched his work and contributed to the development of groundbreaking technologies in cloning.
Conclusion
Marvin M. Pace's contributions to cloning technologies reflect his dedication to innovation and scientific advancement. His patents and collaborations highlight his role as a significant inventor in this important field.